Microfluidic Assay Quantifies Fibrinaloid Clots in Pediatric Long COVID Patients
By
thenerdhead
Summary
This research article presents a study using microfluidic assays to quantify fibrinaloid clots in plasma from pediatric Long COVID patients. The research addresses the significant impact of Long COVID on children, with one in five affected after SARS-CoV-2 infection, causing symptoms like fatigue, brain fog, pain, and shortness of breath that can impair school performance and long-term development. The study focuses on measuring specific blood clot formations in children with Long COVID using advanced microfluidic technology.
Key quotes
· 4 pulledLong COVID (LC) impacts one in five children after an acute SARS-CoV-2 infection
Typical LC symptoms include fatigue, brain fog, pain, and shortness of breath
LC may impair school performance and have long-term health and development impacts
Quantification of fibrinaloid clots in plasma from pediatric Long COVID patients using a microfluidic assay
You might also wanna read
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
newscientist.com·1h ago
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·1h agoExperimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·1h ago
Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds
Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a
npr.org·10h ago
GeneSkin Develops mRNA Therapy Targeting Skin Stem Cells for Rejuvenation and Hair Growth
GeneSkin is developing a novel mRNA therapy targeting basal stem cells in the skin to address a wide range of dermatological issues includin
wyss.harvard.edu·12h ago
ME/CFS Diagnosis and Management in Children and Adolescents: A Clinical Primer
This article is a primer on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in young people, published on PubMed. It highlights
pubmed.ncbi.nlm.nih.gov·1d ago